Linagliptin CAS: 668270-12-0 Utanga ibicuruzwa

Linagliptin (amazina yubucuruzi Tradjenta na Trajetna) ni inzitizi ya dipeptidyl peptidase-4 (DPP-4) yemejwe na FDA yo muri Amerika muri Gicurasi 2011 kugirango ivure diyabete yo mu bwoko bwa 2 hamwe nimirire no gukora siporo.Linagliptin (BI-1356) yasobanuwe nkikintu gikomeye cyatoranijwe cyane, umuvuduko muke hamwe nigihe kirekire cyo gukumira DPP-4.Linagliptin yavuye mubikorwa byo kunoza ingufu za DPP-4 zishingiye kuri xanthine hamwe nintangiriro yambere yagaragaye mubukangurambaga bwa HTS.

Tegeka cyangwa usabe amagambo

Ibicuruzwa birambuye

Ibicuruzwa

Gushyira mu bikorwa n'ingaruka

Linagliptin (TrajentaR, TradjentaTM, TrazentaTM, TrayentaTM) ni umunwa, utoranya cyane inhibitori ya dipeptidyl peptidase-4 kandi niwe mukozi wambere wicyiciro cyayo wavanyweho ahanini binyuze munzira zidasanzwe.Linagliptine yerekanwa inshuro imwe ikoreshwa buri munsi mu kuvura abantu bakuru barwaye diyabete yo mu bwoko bwa kabiri. -1] hamwe na glucose iterwa na insulineotropic peptide) hamwe no kuzenguruka glucose nyuma yo gutangira.

Icyitegererezo cyibicuruzwa

Gupakira ibicuruzwa:

Amakuru yinyongera:

Ibigize	C25H28N8O2
Suzuma	99%
Kugaragara	Ifu yera
URUBANZA No.	668270-12-0
Gupakira	25KG
Ubuzima bwa Shelf	Imyaka 2
Ububiko	Ubike ahantu hakonje kandi humye
Icyemezo	ISO.